RBC Bioscience

RBC Bioscience FCF Yield

The Free Cash Flow Yield of RBC Bioscience (6848.TWO) as of Nov 5, 2026 is 19.85 %. In the previous year, Free Cash Flow Yield was 2.93 % — a change of 576.26% (higher).

FCF Yield

19.85 %

YoY

576.26%

Last updated:

Free Cash Flow Yield of RBC Bioscience is 2024 19.85 % . Free Cash Flow Yield of RBC Bioscience was 2023 2.93 % . It decreases by 576.26% higher compared to the previous year.

The RBC Bioscience FCF Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Yield
Date
FCF Yield
Jan 1, 2018
-28.76 TWD
Jan 1, 2019
13.52 TWD
Jan 1, 2020
37.98 TWD
Jan 1, 2021
-206.88 TWD
Jan 1, 2022
-1.50 TWD
Jan 1, 2023
2.93 TWD
Jan 1, 2024
19.85 TWD
The RBC Bioscience FCF Yield history
YEARFCF YieldYoY
19.85 %+576.26%
2.93 %-295.82%
-1.50 %-99.28%
-206.88 %-644.77%
37.98 %+180.87%
13.52 %-147.01%
-28.76 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

RBC Bioscience Stock analysis

What does RBC Bioscience do? RBC Bioscience Corp manufactures reagents and devices for life science and molecular diagnosis. The company's products include instruments equipped with ultraviolet sterilization systems for nucleic acid purification and disposable reagent strips and tips that work with built-in control programs for different nucleic acid extraction types. The firm developed nucleic acid purification reagents with cellulose-embedded magnetic beads to improve DNA and RNA purity for blood, bacteria, viruses, and forensic examinations. These products are used for future diagnosis, prevention, tracking, and treatment of diseases. The company sells its instruments and reagents to customers in life science and molecular diagnosis sectors. The instruments feature ultraviolet sterilization systems, while the reagents include disposable strips and tips with varying control programs. The reagents with cellulose-embedded magnetic beads are designed for high-purity nucleic acid extraction from diverse samples including blood, bacteria, viruses, and forensic materials. RBC Bioscience Corp's revenue comes from the sale of instruments and reagents. The instruments are sold to laboratories and medical facilities requiring nucleic acid purification systems. The reagents, including the disposable strips and tips, are sold alongside the instruments or separately for ongoing use in molecular diagnosis processes. RBC Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about RBC Bioscience stock

Free Cash Flow Yield of RBC Bioscience is 19.85 % in 2024.

Free Cash Flow Yield of RBC Bioscience changed from 2.93 % to 19.85 %, representing a 576.26% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Yield RBC Bioscience since 2006 – with annual values, charts, and detailed analysis.

FCF Yield measures the free cash flow per share relative to the stock price. It indicates how much cash a company generates for each dollar invested.

To evaluate Free Cash Flow Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Yield's RBC Bioscience with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — RBC Bioscience

All Key Metrics — RBC Bioscience